Daniel H Hwang

Title: The Innovations of Daniel H Hwang

Introduction

Daniel H Hwang is an accomplished inventor based in Baton Rouge, LA. He has made significant contributions to the field of immunology and inflammatory disorders. With a total of 2 patents, Hwang's work focuses on innovative treatments that target severe inflammatory conditions.

Latest Patents

Hwang's latest patents include the "Use of sesquiterpene lactones for treatment of severe inflammatory" and the "Method of use of radicicol for treatment of immunopathological disorders." The first patent highlights the utility of sesquiterpene lactones in suppressing early proinflammatory cytokines, which can ameliorate septic shock and other severe inflammatory disorders. This invention demonstrates how sesquiterpene lactones with an .alpha.-methylene-.gamma.-lactone functional group can inhibit the expression of inducible cyclooxygenase-2 and proinflammatory cytokines in mammalian macrophages. The second patent provides a method for treating immunopathological disorders associated with proinflammatory agents, detailing a compound formula that can effectively target various inflammatory agents.

Career Highlights

Hwang has worked with notable institutions such as Louisiana State University and Agricultural & Mechanical College and The Scripps Research Institute. His research has contributed to advancements in understanding and treating inflammatory diseases.

Collaborations

Some of Hwang's coworkers include Nikolaus H Fischer and Lili Feng, who have collaborated with him on various research projects.

Conclusion

Daniel H Hwang's innovative work in the field of immunology and his patents reflect his commitment to advancing medical treatments for severe inflammatory disorders. His contributions are significant in the ongoing quest for effective therapies.